CytomX Therapeutics, Inc. Capital Expenditures
CytomX Therapeutics, Inc. (CTMX) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- CytomX Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CytomX Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- CytomX Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $201.00K, a 151.25% increase year-over-year.
- CytomX Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was -$127.00K, a 768.42% decline year-over-year.
- CytomX Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $220.00K, a 29.03% decline from fiscal 2024.
- CytomX Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $310.00K, a 63.10% decline from fiscal 2023.
- CytomX Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $840.00K, a 51.72% decline from fiscal 2022.
- CytomX Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.74M, a 8.14% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $201.00K derived: sum of 3 quarters · filed 2026-08-06 | $74.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $201.00K derived: sum of 2 quarters · filed 2026-05-07 | $74.00K derived: sum of 3 quarters · filed 2026-05-07 | $101.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $74.00K derived: sum of 2 quarters · filed 2026-03-16 | $101.00K derived: sum of 3 quarters · filed 2026-08-06 | $220.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$100.00K derived: sum of 2 quarters · filed 2026-08-06 | $19.00K 10-Q · filed 2025-11-06 | $99.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $146.00K 10-Q · filed 2026-08-06 | $226.00K derived: sum of 3 quarters · filed 2026-08-06 | $245.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $119.00K 10-Q · filed 2026-05-07 | $199.00K derived: sum of 2 quarters · filed 2026-05-07 | $218.00K derived: sum of 3 quarters · filed 2026-05-07 | $314.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $99.00K derived: sum of 2 quarters · filed 2026-03-16 | $195.00K derived: sum of 3 quarters · filed 2026-03-16 | $310.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $115.00K derived: sum of 2 quarters · filed 2025-11-06 | $230.00K 10-Q · filed 2025-11-06 | $496.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $211.00K 10-Q · filed 2025-08-07 | $477.00K derived: sum of 3 quarters · filed 2025-08-07 | $486.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $115.00K 10-Q · filed 2025-05-12 | $381.00K derived: sum of 2 quarters · filed 2025-05-12 | $390.00K derived: sum of 3 quarters · filed 2025-05-12 | $907.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $275.00K derived: sum of 2 quarters · filed 2025-03-06 | $792.00K derived: sum of 3 quarters · filed 2025-03-06 | $840.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $526.00K derived: sum of 2 quarters · filed 2024-11-07 | $574.00K 10-Q · filed 2024-11-07 | $756.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $517.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $565.00K 10-Q · filed 2024-08-08 | $747.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.16M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $48.00K 10-Q · filed 2024-05-08 | $230.00K derived: sum of 2 quarters · filed 2024-05-08 | $640.00K derived: sum of 3 quarters · filed 2024-05-08 | $1.05M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $592.00K derived: sum of 2 quarters · filed 2024-03-11 | $1.00M derived: sum of 3 quarters · filed 2024-03-11 | $1.74M 10-K · filed 2024-03-11 |
| 2022-09-30 | $410.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $822.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.56M 10-Q · filed 2023-11-07 | $1.80M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.15M 10-Q · filed 2023-08-08 | $1.39M derived: sum of 3 quarters · filed 2023-08-08 | $1.66M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $736.00K 10-Q · filed 2023-05-09 | $981.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.25M derived: sum of 3 quarters · filed 2023-05-09 | $1.36M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $245.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | $513.00K derived: sum of 2 quarters · filed 2023-03-27 | $627.00K derived: sum of 3 quarters · filed 2023-03-27 | $1.61M 10-K/A · filed 2023-03-27 |
| 2021-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $382.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.36M 10-Q · filed 2022-11-08 | $1.81M derived: sum of 4 quarters · filed 2023-03-27 |
| 2021-06-30 | $114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.10M 10-Q · filed 2022-08-04 | $1.54M derived: sum of 3 quarters · filed 2023-03-27 | $2.32M derived: sum of 4 quarters · filed 2023-03-27 |
| 2021-03-31 | $982.00K 10-Q · filed 2022-05-05 | $1.43M derived: sum of 2 quarters · filed 2023-03-27 | $2.21M derived: sum of 3 quarters · filed 2023-03-27 | $2.24M derived: sum of 4 quarters · filed 2023-03-27 |
| 2020-12-31 | $445.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | $1.22M derived: sum of 2 quarters · filed 2023-03-27 | $1.26M derived: sum of 3 quarters · filed 2023-03-27 | $2.31M 10-K/A · filed 2023-03-27 |
| 2020-09-30 | $778.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $815.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.86M 10-Q · filed 2021-11-04 | $2.57M derived: sum of 4 quarters · filed 2023-03-27 |
| 2020-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.09M 10-Q · filed 2021-08-05 | $1.79M derived: sum of 3 quarters · filed 2023-03-27 | $2.42M derived: sum of 4 quarters · filed 2023-03-27 |
| 2020-03-31 | $1.05M 10-Q · filed 2021-05-06 | $1.75M derived: sum of 2 quarters · filed 2023-03-27 | $2.38M derived: sum of 3 quarters · filed 2023-03-27 | $2.71M derived: sum of 4 quarters · filed 2023-03-27 |
| 2019-12-31 | $703.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | $1.33M derived: sum of 2 quarters · filed 2023-03-27 | $1.66M derived: sum of 3 quarters · filed 2023-03-27 | $3.50M 10-K/A · filed 2023-03-27 |
| 2019-09-30 | $628.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $959.00K derived: sum of 2 quarters · filed 2020-11-05 | $2.79M 10-Q · filed 2020-11-05 | $3.91M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $331.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.17M 10-Q · filed 2020-08-06 | $3.29M derived: sum of 3 quarters · filed 2021-02-24 | $4.33M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.83M 10-Q · filed 2020-05-07 | $2.95M derived: sum of 2 quarters · filed 2021-02-24 | $4.00M derived: sum of 3 quarters · filed 2021-02-24 | $4.87M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.17M derived: sum of 2 quarters · filed 2021-02-24 | $3.04M derived: sum of 3 quarters · filed 2021-02-24 | $3.79M 10-K · filed 2021-02-24 |
| 2018-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.92M derived: sum of 2 quarters · filed 2019-11-07 | $2.67M 10-Q · filed 2019-11-07 | $2.90M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $868.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.62M 10-Q · filed 2019-08-07 | $1.85M derived: sum of 3 quarters · filed 2020-02-27 | $1.91M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $751.00K 10-Q · filed 2019-05-09 | $985.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.04M derived: sum of 3 quarters · filed 2020-02-27 | $1.37M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $291.00K derived: sum of 2 quarters · filed 2020-02-27 | $615.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.56M 10-K · filed 2020-02-27 |
| 2017-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $381.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.32M 10-Q · filed 2018-11-06 | $1.93M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.27M 10-Q · filed 2018-08-08 | $1.87M derived: sum of 3 quarters · filed 2019-02-27 | $2.73M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $944.00K 10-Q · filed 2018-05-09 | $1.55M derived: sum of 2 quarters · filed 2019-02-27 | $2.41M derived: sum of 3 quarters · filed 2019-02-27 | $2.79M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $602.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.47M derived: sum of 2 quarters · filed 2019-02-27 | $1.85M derived: sum of 3 quarters · filed 2019-02-27 | $2.18M 10-K · filed 2019-02-27 |
| 2016-09-30 | $863.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.25M derived: sum of 2 quarters · filed 2017-11-07 | $1.57M 10-Q · filed 2017-11-07 | $1.76M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $384.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $711.00K 10-Q · filed 2017-08-07 | $893.00K derived: sum of 3 quarters · filed 2018-03-07 | $1.26M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $327.00K 10-Q · filed 2017-05-05 | $509.00K derived: sum of 2 quarters · filed 2018-03-07 | $872.00K derived: sum of 3 quarters · filed 2018-03-07 | $1.67M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $545.00K derived: sum of 2 quarters · filed 2018-03-07 | $1.34M derived: sum of 3 quarters · filed 2018-03-07 | $1.59M 10-K · filed 2018-03-07 |
| 2015-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.16M derived: sum of 2 quarters · filed 2016-11-03 | $1.41M 10-Q · filed 2016-11-03 | $2.08M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $794.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $1.05M 10-Q · filed 2016-08-03 | $1.71M derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | $255.00K 10-Q · filed 2016-05-06 | $919.00K derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $664.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $1.66M 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $999.00K 10-Q · filed 2015-11-23 | |||
| 2013-12-31 | $732.00K 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |